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first, third and fourth treatment sessions. Heat with mobile 
insulator sheets was used during the second and fourth 
treatment sessions. The mobile insulator sheets comprised 
silicon rubber of 1.0 mm in thickness, which covered 75% of 
the surface of both the electrodes. The sheets were 
alternately arranged and moved in parallel at certain 
intervals. The intra-rectal temperature was measured using a 
four-point microthermocouple sensor during the heating. 
Several thermal parameters between the sessions with and 
without the mobile insulator sheets were evaluated. 
Results: Ten patients with pelvic tumors (eight cases of 
prostate cancer, two cases of cervical cancer of the uterus) 
were eligible for the study. All 10 patients could receive the 
planned five HT sessions. A planned heating time of 50 
minutes was completed in 15 (75%) of 20 HT sessions with 
mobile insulator sheets and in 25 (83%) of 30 HT sessions 
without them. A thermal parameter of the cumulative 
equivalent minutes at 43ºC for the T90 (CEM43 ºCT90) was 
1.9 minutes during the HT sessions with mobile insulator 
sheets and 1.2 minutes during the HT sessions without them, 
and this difference was statistically significant (p<0.05). The 
median minimum intra-rectal temperature (Tmin) was 40.8ºC 
during HT sessions with mobile insulator sheets and 40.6ºC 
during HT sessions without them, which was also a significant 
difference (p<0.05).  
Conclusions: This clinical prospective study demonstrated 
that the novel deep heating method using an 8 MHz 
radiofrequency-capacitive heating device with the mobile 
insulator sheets could improve the temperature increase of 
deep-seated tumors of the pelvis.  
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Purpose/Objective: External beam radiotherapy is commonly 
used for treatment of prostate cancer as it has shown 
excellent results. However, efficacy depends on accurate 
delivery of radiation doses to the prostate. Factors that 
affect prostate positioning include setup errors, as well as 
changes in the bladder and rectal volume. Before 2012, 
patients at our centre were treated with an empty bladder to 
minimise potential variations in bladder filling and thus 
prostate position. Current protocol is to treat our patients 
with a full bladder to reduce side effects on the small bowels 
as full bladder allows displacement of the small bowel 
cranially and minimises volume within treatment fields. 
Inter-fraction prostate motion on the 'bladder – empty' 
protocol at our centre was analysed in a 2011 paper by Siow 
et al, showing that setup errors and inter-fraction prostate 
movements were small, with >80% of the setup errors within 
+/- 2mm. Our study was aimed at comparing the 'bladder – 
empty' protocol utilising this prior paper, with the 'bladder – 
full' protocol for a comparison inter-fraction prostate motion.  
Materials and Methods: A total of 105 prostate cancer 
patients were treated with radical doses of radiotherapy to 
the prostate in 2013 with 3823 fractions in total. The patients 
were planned for treatment in the supine position, and skin 
tattoos placed as external reference markers. Daily shifts 
were measured based on image registration of the planning 
computed tomography (pCT) to the daily cone-beam CT 
(CBCT) images acquired pre-treatment. Images were first 
registered using automatic bony-match followed by manual 
matching of the soft tissues based on prostate and seminal 
vesicles. Shifts in the anterior-posterior (AP), superior-
inferior (SI) and right-left (RL) dimensions were measured 
and analysed. 
Results: With the bladder – full protocol, our shifts in all 
three directions were small, with most of the shifts falling 
within +/- 2mm and normally distributed. Our results show 
statistical significance in all directions, with reduced shifts 
especially in the SI and RL directions, but increased in the AP 
directions, when compared with the 'empty – bladder' 
protocol (p<0.0001). This might be a result of the 
full/partially filled bladder flopping downwards posteriorly 
exerting pressure on the prostate, as well as forward 
pressure from rectal filling. Applying the Van Herk formula 
(2.5∑ + 0.7σ), the calculated CTV-PTV margins in the AP, SI 
and RL were respectively 6.14mm, 4.05mm and 5.65mm for 
the 'bladder – full' protocol compared with 6.37mm, 6.22mm 
and 5.69mm for the 'bladder – empty' protocol. 
Conclusions: In addition to sparing of small bowels, the 
bladder – full protocol is effective in reducing inter-fraction 
prostate motion compared to the 'bladder – empty' protocol, 
with the possibility of reduced treatment margins and 
irradiated volume. Thus, the bladder – full protocol is 
preferred as the standard treatment preparation for all 
prostate cancer patients.  
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Purpose/Objective: The purpose of the study was to review 
the intra-fraction reproducibility and inter-observer 
variability with image guidance for patients being treated in 
a relocatable stereotactic head frame for radiosurgery on the 
TomoTherapy platform. 
Materials and Methods: Seven patients were treated in a 
relocatable Gill-Thomas-Cosman (GTC) stereotactic head 
frame, all of whom received stereotactic radiosurgery for 
solitary intra-cranial metastases, using a PTV margin of zero. 
Following our standard protocol, image guidance was 
performed prior to treatment, including MVCT acquisition, 
image matching and positional correction. The treatment 
dose was divided in half in order to allow re-imaging, re-
matching and re-positioning half way through treatment. A 
further image guidance MVCT was acquired at the end of the 
S704                                                                                                                                         3rd ESTRO Forum 2015 
 
treatment. Image matching was performed initially using the 
auto match feature on the TomoTherapy platform and 
positioning was then refined by the treating radiographers. In 
addition to the initial radiographer who performed matching 
at time of treatment, a further two radiographers repeated 
the image matching process in order to provide information 
about inter-observer variability. 
Results: The results of intra-fraction motion include 
components both of positional change and also residual error 
in inter-observer image matching. The inter-observer 
variation had a standard deviation of 0.6mm left-right (LR), 
0.3mm anterior-posterior (AP) and 0.9mm cranio-caudal (CC). 
Intra-fraction motion had a mean positional change 
approximately 0 in LR and AP and 0.6mm CC. The standard 
deviations were 0.7, 0.6 and 1.0mm in LR, AP and CC 
directions. Using the standard van Herk PTV margin recipe1, 
the margin required to allow for these two components of 
uncertainty is 2.3mm LR, 1.7mm AP and 3.4 mm CC. 
Conclusions: The PTV margin component attributable to 
intra-fraction motion and inter-observer matching is bigger 
than expected, and bigger than used. When using high dose 
single fraction radiosurgery, the standard PTV margin recipe 
may be unnecessarily generous. Work is on-going to resolve 
the difference between the ‘ideal’ PTV margin and the 
‘clinically practical’ margin currently in use. 
References: 
1. Van Herk et al. The probability of correct target dosage: 
dose-population histograms for deriving treatment margins in 
radiotherapy IJROBP 47: 1121-1135, 2000. 
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Purpose/Objective: To evaluate the safety of Stereotactic 
Body Radiotherapy (SBRT) of bone metastases in 
oligometastatic disease and to investigate possible predictive 
factors of local control (LC), progression disease free survival 
(PDFS) and overall survival (OS).  
Materials and Methods: Main eligibility criteria were number 
of metastatic sites ≤5, controlled primary tumor with no 
evidence of progression under systemic therapies, exclusion 
of surgery and no previous radiotherapy of the lesion of 
interest. Patients were classified into two categories: only 
bone (BOD) and outside bone oligometastatic disease (OBOD). 
SBRT was delivered only to bone lesions using two different 
schedules: 24Gy/1fraction or 27Gy/3 fractions. 
Results: Between January 2010 and December 2013, 40 
patients were enrolled in our study. The most frequent 
primary tumors were prostate (40%), breast (17,5%) and lung 
cancer (15%). Two patients experienced severe late toxicity 
(fracture of the treated site). LC was longer among 
'Responders' than 'Not responders' lesions (94,2% and 91,2% 
versus 50% and 16,6% at 1 and 2 years, respectively) 
(p=0,004). The multivariate analysis of PDFS showed a 
significant correlation with PTV volume (p=0,003) and 
Oligometastatic Status (p=0,002). The multivariate analysis of 
OS, confirmed a statistical significant value of the 
Oligometastatic Status (p=0,002) whereas no correlation was 
proved for PTV volume (p=0,065).  
Conclusions: SBRT of bone metastases is safe with a low 
incidence of severe toxicity. PET response has proven to be a 
strong predictive factor of LC whereas the BOD status and the 
small size of bone metastases might identify a subset of 
oligometastatic patients at better prognosis. 
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Purpose/Objective: The aim of this study is to present an 
innovative QA methodology for patient-specific plan 
verification through true measurements of DVHs and 
comparisons with the corresponding TPS-calculated DVHs. 
Materials and Methods: 3D-printing technology and polymer 
gel dosimetry were combined in a unique way in order to 
construct a patient-specific QA phantom (patient-specific 
dosimetry phantom - PSDP). The selected patient planning-CT 
scans were used for the construction of a patient-specific 3D-
printed model (external surface and bone structures). The 
3D-printed model was subsequently filled with Vinyl-
Pyrrolidone (VIPAR) polymer gel. The constructed PSDP was 
then treated as if it the real patient, i.e. 'immobilization', 
set-up, image guidance (e.g. CBCT) and irradiation were 
implemented on the phantom. The irradiated PSDP was then 
MRI-scanned (derivation of T2-maps). The T2-maps of the 
PSDP contain dosimetric information that was extracted by 
analyzing the polymer gel dosimetry data. These PSDP T2-
maps that contain dosimetric information, were subsequently 
imported to the TPS and were registered/fused to the real 
patient planning-CT scans and RStructure dicom-RT data. This 
way, the PSDP measured dose pattern was spatially 
correlated with the real patient RStructure information, 
allowing the measurements of DVHs.  
Results: True patient-specific DVHs measurements were 
implemented following the proposed methodology. DVHs 
measurements were directly compared with the 
corresponding TPS-calculated DVHs. The QA and evaluation of 
the validity of overall treatment chain, of the treatment 
outcome and patient safety was feasible. 
Conclusions: True patient-specific DVHs can be measured for 
the first time and compared against the TPS-calculated 
corresponding DVHs, following the proposed methodology. 
Patient-specific treatment outcome and patient safety could 
